1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine (ECyd, tas-106)1:: Antitumor effect and mechanism of action

被引：22

作者：

Azuma, A ^{[1
]}

Matsuda, A

Sasaki, T

Fukushima, M

机构：

[1] Taiho Pharmaceut Co Ltd, Hanno, Saitama 3578527, Japan

[2] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido, Japan

[3] Kanazawa Univ, Canc Res Inst, Kanazawa, Ishikawa 920, Japan

来源：

NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS | 2001年 / 20卷 / 4-7期

关键词：

D O I：

10.1081/NCN-100002337

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The antitumor activity, cellular metabolism and mechanism of action of the antitumor nucleoside analog, 1-(3-C-ethynyl-beta -D-ribo-pentofuranosyl)cytosine (ECyd) are described.

引用

页码：609 / 619

页数：11

共 14 条

[1]

AZUMA A, 1999, P AM ASSOC CANC RES, V40, P1999

[2] Nucleosides and nucleotides.: 175.: Structural requirements of the sugar moiety for the antitumor activities of new nucleoside antimetabolites, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine and -uracil [J].

Hattori, H ;

Nozawa, E ;

Iino, T ;

Yoshimura, Y ;

Shuto, S ;

Shimamoto, Y ;

Nomura, M ;

Fukushima, M ;

Tanaka, M ;

Sasaki, T ;

Matsuda, A .

JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (15) :2892-2902

[3] Nucleosides and nucleotides .158. 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil, and their nucleobase analogues as new potential multifunctional antitumor nucleosides with a broad spectrum of activity [J].

Hattori, H ;

Tanaka, M ;

Fukushima, M ;

Sasaki, T ;

Matsuda, A .

JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (25) :5005-5011

[4]

HUANG P, 1991, CANCER RES, V51, P6110

[5]

HUANG P, 1991, MOL PHARMACOL, V39, P449

[6] New antimetabolites in cancer chemotherapy and their clinical impact [J].

Kaye, SB .

BRITISH JOURNAL OF CANCER, 1998, 78 (Suppl 3) :1-7

[7]

KEATING MJ, 1982, JAMA-J AM MED ASSOC, V248, P2481, DOI 10.1001/jama.248.19.2481

[8]

KUFE DW, 1980, J BIOL CHEM, V255, P8997

[9] Nucleosides and nucleotides .152. 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil as a broad spectrum antitumor nucleoside [J].

Matsuda, A ;

Hattori, H ;

Tanaka, M ;

Sasaki, T .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (16) :1887-1892

[10] Gemcitabine - A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer [J].

Noble, S ;

Goa, KL .

DRUGS, 1997, 54 (03) :447-472

← 1 2 →